Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.38 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.38 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.36 |
| ▸ | AHR | P35869 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.34 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18326981 | 1.00 | CA12 (0.41) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL18326987 | 0.99 | CA12 (0.42) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL18326986 | 0.98 | CA12 (0.41) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL18326982 | 0.98 | CA12 (0.41) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL18326974 | 0.98 | CA12 (0.43) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL23237332 | 0.96 | CA12 (0.38) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL23224523 | 0.96 | MCL1 (0.39) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL18326985 | 0.96 | CA12 (0.41) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL23239560 | 0.96 | MCL1 (0.39) | CA12CA1CA2CA9PLA2G2A | |
| SCHEMBL18326976 | 0.96 | CA12 (0.41) | CA12CA1CA2CA9PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200290986-A1 | MONO AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-09-17 | — | — | US | disclosed |
| US-10693079-B2 | Mono amine derivatives and organic electroluminescent device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-23 | — | — | US | disclosed |
| US-20160372677-A1 | MONO AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-12-22 | — | — | US | disclosed |
| US-20160372677-A1 | MONO AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200290986-A1 | MONO AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | MAOA, MAOB, TAAR1 | CA12 4167/4885CA1 4106/4885CA2 3624/4885 |
| US-10693079-B2 | Mono amine derivatives and organic electroluminescent device including the same | CHRM1, NAP1L1, NAT1 | CA12 4202/4885CA1 3804/4885CA2 3701/4885 |
| US-20160372677-A1 | MONO AMINE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | CHRM1, NAP1L1, NAT1 | CA12 4202/4885CA1 3804/4885CA2 3701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.